(Q43820687)

English

A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand

scientific article published on 7 December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

based on heuristic

inferred from title

Kenrad E. Nelson

4

object named as

Kenrad E Nelson

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Suwat Chariyalertsak

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Khuanchai Supparatpinyo

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Thira Sirisanthana

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

7 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

277-284

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Coccidioidomycosis in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

Disseminated Penicillium marneffei infection in southeast Asia

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

Discontinuation of Secondary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

The spectrum of AIDS-defining diseases: temporal trends in Italy prior to the use of highly active anti-retroviral therapies, 1982-1996

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis againstPneumocystis cariniiPneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection

1 reference

https://api.crossref.org/works/10.1086%2F338154

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43820687&oldid=2103643676"